FDA Inspection
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited – FDA Inspection, Nov 6, 2023
Record Details
This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on November 6, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 01fa4df9-a921-4e9e-be5f-bd7dcb845d86
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224917
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Takeda Pharmaceutical Company Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2023 | Not classified | Office of Inspections and Investigations | |
| July 19, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 26, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Takeda Pharmaceutical Company Limited
- FDA Inspection 1218059 - 2023-05-24
- FDA Inspection 1148832 - 2021-07-19
- FDA Inspection 1111495 - 2019-11-26
- FDA Inspection 1033814 - 2017-11-07
- FDA Inspection 951603 - 2015-10-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.